搜尋
Heartflow Inc
HTFL添加自選
30.710USD
+1.370+4.67%
收盤 07/01, 16:00（美東）報價延遲15分鐘
2.62B總市值
虧損本益比TTM
關鍵數據
29.350今開
30.770最高
2.02M成交量
虧損本益比TTM
虧損本益比動
--股利TTM
2.37%換手率
29.340昨收
28.890最低
44.41M成交額
虧損本益比靜
8.71市淨率
0.00%股息率 TTM
-42.32%ROA
41.22352週最高
0.46量比
-96.43M淨利潤
85.28M總股本
-3.0875每股盈餘TTM
--Beta
--ROE
20.13052週最低
6.41%振幅
80.18%毛利率
2.62B總市值
-0.16回報/風險
4.58%風險率
TradingKey Heartflow Inc股票評分
單位: USD 更新時間: 2026-06-30操作建議
Heartflow Inc當前公司基本面數據相對健康，增長潛力很大。當前估值合理，在醫療設備與耗材行業排名116/204位。機構持股佔比非常高，近一月多位分析師給出公司評級為買入。最高目標價為37.40。中期看，股價處於上升通道。近一個月，市場表現一般，但基本面評分較高。目前股價在壓力位和支撐位之間，可以做區間波段操作。
Heartflow Inc評分
壓力支撐
由於公司未披露，未能獲取相關數據
多維評測
本期評分
上期評分
公司輿情
過去24小時
熱度
過冷
過熱
看空
Heartflow Inc亮點
亮點風險
HeartFlow Inc. is a commercial-stage medical technology company that has pioneered the use of software and artificial intelligence (AI) to deliver a non-invasive solution for diagnosing and managing coronary artery disease (CAD). The Company’s novel HeartFlow Platform uses AI and advanced computational fluid dynamics to create a personalized three-dimensional (3D) model of a patient’s heart based on a single coronary computed tomography angiography (CCTA). Its AI-driven platform includes Roadmap Analysis, FFRCT Analysis and Plaque Analysis. The HeartFlow FFRCT Analysis and Plaque Analysis software assists physicians in diagnosing, managing and delivering precision care to patients with CAD. The RoadMap Analysis offers a highly intuitive anatomic visualization of the coronary arteries, helping physicians quickly identify clinically relevant areas to focus their review.
業績高增長
公司營業收入穩步增長，連續3年增長101.93%
估值低估
公司最新PE估值-9.50，處於3年歷史低位
分析師目標
基於
7
分析師
買入
評級
37.400
目標均價
+27.47%
漲幅空間
Heartflow Inc新聞
即將為您帶來更多新聞，敬請期待。 。 。
財務指標
每股收益
由於公司未披露，未能獲取相關數據
營業總收入
由於公司未披露，未能獲取相關數據
Heartflow Inc簡介
HeartFlow Inc. is a commercial-stage medical technology company that has pioneered the use of software and artificial intelligence (AI) to deliver a non-invasive solution for diagnosing and managing coronary artery disease (CAD). The Company’s novel HeartFlow Platform uses AI and advanced computational fluid dynamics to create a personalized three-dimensional (3D) model of a patient’s heart based on a single coronary computed tomography angiography (CCTA). Its AI-driven platform includes Roadmap Analysis, FFRCT Analysis and Plaque Analysis. The HeartFlow FFRCT Analysis and Plaque Analysis software assists physicians in diagnosing, managing and delivering precision care to patients with CAD. The RoadMap Analysis offers a highly intuitive anatomic visualization of the coronary arteries, helping physicians quickly identify clinically relevant areas to focus their review.
公司代碼HTFL
公司Heartflow Inc
CEOFarquhar (John C. M)
網址https://www.heartflow.com/
相關品種
+2.62%
+2.41%
+1.57%
+1.18%
+1.73%
+1.30%
-0.50%
+1.27%
+7.60%
+0.88%
+0.39%
+0.89%
+1.92%
+1.70%
+3.09%
+2.12%
+1.08%
+1.78%
+0.41%
+0.78%熱門品種
52243.200
-11.100 (-0.02%)
29757.400
-41.900 (-0.14%)
7475.100
-0.400 (-0.01%)
15340.000
-15.000 (-0.10%)
68814.000
-671.000 (-0.97%)
6269.400
-6.000 (-0.10%)
67.664
-0.304 (-0.45%)
294.380
+5.020 (+1.73%)
197.580
-2.510 (-1.25%)
4045.350
+14.580 (+0.36%)
常見問題
Heartflow Inc(HTFL)的當前股價是多少？
Heartflow Inc(HTFL)的當前股價是 30.71。
Heartflow Inc 的股票代碼是什麼？
Heartflow Inc的股票代碼是HTFL。
Heartflow Inc股票的52週最高點是多少？
Heartflow Inc股票的52週最高點是41.22。
Heartflow Inc股票的52週最低點是多少？
Heartflow Inc股票的52週最低點是20.13。
Heartflow Inc的市值是多少？
Heartflow Inc的市值是2.62B。
現在Heartflow Inc(HTFL)的股票是買入、持有還是賣出？
根據分析師評級，Heartflow Inc(HTFL)的總體評級為買入，目標價格為37.40。
Heartflow Inc(HTFL)股票的每股收益（EPS TTM）是多少
Heartflow Inc(HTFL)股票的每股收益（EPS TTM）是-3.17。